Butcher’s Broom for Circulation and Lymphatic Health

Published by Lymphatic Health Co., the company behind Lympha.

Butcher’s broom has a clear place in the conversation about lymphatic health. Human research has linked specific preparations to improvements in leg swelling, heaviness, and tension. Those outcomes matter because the veins and lymphatic vessels work together to maintain fluid balance in the tissues.

For Lympha, that connection is central. We selected butcher’s broom for its relevance to venous function and leg comfort, as part of a formula designed around the wider fluid-balance system. Understanding its role starts with what the plant contains and what researchers have actually measured.

What is butcher’s broom

Butcher’s broom, or Ruscus aculeatus, is an evergreen shrub with a long history of use in European herbal preparations. Its compounds include steroidal saponins associated with ruscogenin and neoruscogenin, collectively measured as ruscogenins. These are useful markers when describing the composition of an extract.

Much of the clinical research has used preparations from the rhizome, the plant’s underground stem. The European Medicines Agency’s assessment explains the plant chemistry and the extract types used in research.

Why venous support matters to lymphatic health

Veins carry blood back toward the heart. Lymphatic vessels collect fluid and proteins from the spaces around cells and return them to the circulation. Pressure in the blood vessels helps determine how much fluid moves into those spaces and how much the lymphatic system must carry away.

When venous pressure remains elevated, more fluid can filter into the tissues, increasing the demand on lymphatic drainage. This relationship provides a physiological reason to consider venous support when thinking about lymphatic health. The National Cancer Institute’s overview describes these connected influences on tissue-fluid balance.

Butcher’s broom is relevant here because of its effects on venous tone, the tension generated by muscle in the vein wall. In laboratory experiments using human vein tissue, Ruscus extract produced contractions in the vessels. This experimental finding helps explain the interest in its venous-support potential.

The practical rationale is to support the circulation that influences fluid accumulation, potentially easing the load on lymphatic drainage. We explore that relationship further in Why Circulation Matters for Lymphatic Health.

What the human research shows

A placebo-controlled trial of butcher’s broom alone

A 2002 randomized, double-blind trial enrolled 166 women with chronic venous insufficiency, a condition in which the leg veins have difficulty returning blood efficiently. Researchers compared a specific butcher’s broom preparation with placebo over 12 weeks; 148 participants contributed to the main analysis.

The trial preparation was a defined rhizome extract taken twice daily, supplying approximately 9 mg of total ruscogenins per day. Compared with placebo, it produced greater reductions in leg volume and ankle and lower-leg circumference. At week 12, the between-group difference in leg-volume change was approximately 20.5 mL.

Heavy, tired legs and the sensation of tension also improved. The benefits were specific to swelling and leg symptoms; overall quality-of-life scores were unchanged. This trial gives butcher’s broom a concrete clinical foundation: objective measurements of swelling accompanied by improvements in how the legs felt.

A broader record of venous research

A 2017 systematic review and meta-analysis brought together 10 placebo-controlled trials involving 719 participants with chronic venous disease. It found improvements in heaviness, pain, the feeling of swelling, and objective measures including ankle circumference and leg or foot volume.

The review included the standalone trial above and several combination preparations, including products containing Ruscus, hesperidin methyl chalcone, and vitamin C. These combination results apply to the preparations tested. Hesperidin methyl chalcone is a derivative of hesperidin and differs from the hesperidin used in Lympha.

Together, these findings explain why butcher’s broom remains relevant to formulation decisions about circulation and leg comfort. The research connects it with outcomes people can recognize and researchers can measure.

What the lymphedema research adds

There is also a clinical study directly involving lymphedema. In a 1996 double-blind, placebo-controlled trial, 57 patients with arm lymphedema following breast cancer treatment received the Ruscus-containing combination CYCLO 3 FORT or placebo for three months. All participants also received manual lymphatic drainage twice weekly for at least one month.

The combination group had a statistically significant improvement in arm edema compared with placebo. This is an encouraging finding in an adjunctive-care setting: researchers evaluated an oral preparation alongside established lymphatic therapy.

Because the study tested a combination, it cannot isolate butcher’s broom’s contribution or establish a treatment effect for Lympha. It does provide a reason for continued research into how Ruscus-containing preparations might complement lymphedema care. For someone with diagnosed lymphedema, that discussion belongs within a clinician-guided plan that includes appropriate compression, movement, skin care, and lymphatic therapy.

Why we included butcher’s broom in Lympha

Every 4 mL daily serving of Lympha provides 150 mg of butcher’s broom extract. Our label identifies it as a whole-herb extract, and our formulation specification is 10:1. That ratio describes extraction concentration; ruscogenin content requires a separate specification. The clinical trial above used a defined rhizome preparation.

We selected butcher’s broom for the venous-support side of the formula. Diosmin and hesperidin provide the main connection to the wider venous-health literature. Grape seed extract adds research on circulation and fluid accumulation, while Centella asiatica contributes research on capillary filtration and microcirculation. Butcher’s broom brings its own human evidence on leg volume and heaviness to that rationale.

Each ingredient has a reason for being included. The aim is to support connected processes that influence fluid balance, with every active and daily amount disclosed. The finished Lympha formula has not been clinically tested; our confidence in its design comes from the relevance of the ingredient research and a clear purpose for each component.

What to know about daily use

The studies discussed here evaluated regular use over weeks to months. That makes consistency a more useful starting point than expecting an immediate change. Follow the product’s directions and discuss persistent swelling with a healthcare professional.

Butcher’s broom preparations can cause digestive side effects, including diarrhea. Ask a clinician or pharmacist to review use if you take medication or have a medical condition, particularly diabetes. Use during pregnancy or breastfeeding is not recommended because safety has not been established. See Memorial Sloan Kettering’s ingredient guidance and the EMA assessment linked above.

Butcher’s broom earns its place in Lympha through research relevant to venous function, swelling, and leg comfort. Its contribution fits our approach to lymphatic health: consider the circulation and tissue environment that shape the work the lymphatic system has to do.

Explore the Lympha Evidence Library for the studies and formulation details behind each ingredient.

This article is for general education. Lympha is not intended to diagnose, treat, cure, or prevent any disease.